Search FOXOW
FOXO TECHNOLOGIES INC.
OTC, OTC · CIK 1812360
Last close0.01
Daily changen/a
10 Years gain+0.00%
Dividends TTM0
Dividend yieldn/a
Fundamental Analysis
FOXOW · STANDARD
SIC 8731 · Services-Commercial Physical & Biological Research · Fiscal year end 1231
Fundamental
69.4Momentum
100.0Acceleration
100.0Confidence
82.0Annual Revenue5
Quarterly Revenue18
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality20.9 / 25
Capital Efficiency20.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 43.2544 percentage points.
Operating leverageOperating margin improved by 156.5505 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM158.51%OK
Revenue CAGR 3Y217.58%OK
Gross Margin143.25%OK
Operating Margin43.86%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC121.66%OK
Incremental Operating Margin 3Y281.71%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $16.37M | $16.37M | -$10.33M | -$3.87M | -$3.93M | 100% | -63.11% | -23.99% | -100.79% | n/a |
| 2025 FY Dec 31, 2024 | $4.05M | $4.05M | -$7.76M | -$2.84M | n/a | 100% | -191.58% | n/a | n/a | n/a |
| 2024 FY Dec 31, 2023 | $145,291.00 | $145,291.00 | -$22.19M | -$6.65M | n/a | 100% | -15,271.16% | n/a | n/a | n/a |
| 2023 FY Dec 31, 2022 | $511,000.00 | $167,000.00 | -$40.17M | -$23.76M | -$23.87M | 32.68% | -7,860.47% | -4,671.23% | n/a | n/a |
| 2022 FY Dec 31, 2021 | $120,000.00 | $120,000.00 | -$15.03M | -$15.06M | -$15.17M | 100% | -12,525.83% | -12,644.17% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $18.65M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-038401, 0001493152-25-021497 |
| Revenue Growth TTM | 158.51% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-038401, 0001493152-25-021497 |
| Revenue CAGR 3Y | 217.58% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-016725 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001493152-26-016725 |
| Gross Profit CAGR 3Y | 361.06% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-016725 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-038401, 0001493152-25-021497 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 143.25% | Gross Profit / Revenue | OK | 0001493152-26-038401, 0001493152-25-021497 |
| Operating Margin | 43.86% | Operating Income / Revenue | OK | 0001493152-26-038401, 0001493152-25-021497 |
| ROIC | 121.66% | NOPAT / Average Invested Capital | OK | 0001493152-26-038401, 0001493152-25-021497 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-038401 |
| Current Ratio | 0.12x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001493152-26-016725 |